ALNY : Summary for Alnylam Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
46.86-1.42 (-2.94%)
At close: 4:00PM EST

46.00 -0.86 (-1.84%)
After hours: 5:12PM EST

People also watch
BMRNACORSGENACADALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close48.28
Open48.59
Bid45.50 x 100
Ask47.10 x 300
Day's Range46.37 - 48.59
52 Week Range31.38 - 80.11
Volume646,410
Avg. Volume1,152,159
Market Cap4.03B
Beta3.16
PE Ratio (TTM)-9.78
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Better Buy: Alnylam Pharmaceuticals, Inc. vs. BioMarin Pharmaceutical Inc.
    Motley Foolyesterday

    Better Buy: Alnylam Pharmaceuticals, Inc. vs. BioMarin Pharmaceutical Inc.

    These two biotech stocks have been moving in opposite directions. Which one is the better choice at the moment?

  • Capital Cube7 days ago

    ETFs with exposure to Alnylam Pharmaceuticals, Inc. : February 14, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Alnylam Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ALNY-US. Comparing the performance and risk of Alnylam Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alnylam Pharmaceuticals, Inc. :ALNY-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017
    Capital Cube8 days ago

    Alnylam Pharmaceuticals, Inc. :ALNY-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017

    Categories: Yahoo Finance Get free summary analysis Alnylam Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Alnylam Pharmaceuticals, Inc. – Arrowhead Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., PAREXEL International Corporation, Novartis AG Sponsored ADR and Sanofi Sponsored ADR (ARWR-US, REGN-US, PRXL-US, NVS-US and SNY-US) that ... Read more (Read more...)